重度哮喘中的生物制剂与个性化医疗：一步一个脚印。 - Suppr

Suppr

超能文献

Biologics and Personalized Medicine in Severe Asthma: One Step at a Time.

作者信息

Beasley Richard, Hatter Lee

机构信息

Medical Research Institute of New Zealand, Wellington, New Zealand.

出版信息

J Allergy Clin Immunol Pract. 2023 Jun;11(6):1771-1772. doi: 10.1016/j.jaip.2023.04.022.

DOI:10.1016/j.jaip.2023.04.022

PMID:37295859

Abstract

摘要

相似文献

Biologics and Personalized Medicine in Severe Asthma: One Step at a Time.

J Allergy Clin Immunol Pract. 2023 Jun;11(6):1771-1772. doi: 10.1016/j.jaip.2023.04.022.

Biologics in asthma--the next step toward personalized treatment.

J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):152-60; quiz 161. doi: 10.1016/j.jaip.2014.09.014.

Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.

MAbs. 2018 Jan;10(1):34-45. doi: 10.1080/19420862.2017.1392425. Epub 2017 Nov 14.

Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine.

Curr Opin Pulm Med. 2022 May 1;28(3):266-273. doi: 10.1097/MCP.0000000000000861. Epub 2022 Feb 7.

Biologics in severe asthma: Which one, When and Where?

Clin Exp Allergy. 2021 Sep;51(9):1225-1228. doi: 10.1111/cea.13989. Epub 2021 Jul 26.

Going Beyond "Bio-markers," Think "Life-markers".

Chest. 2020 Mar;157(3):503-505. doi: 10.1016/j.chest.2019.08.2210.

Severe T2-high asthma in the biologics era: European experts' opinion.

Eur Respir Rev. 2019 Jul 8;28(152). doi: 10.1183/16000617.0054-2019. Print 2019 Jun 30.

Biologics for paediatric severe asthma: trick or TREAT?

Lancet Respir Med. 2019 Apr;7(4):294-296. doi: 10.1016/S2213-2600(19)30045-1. Epub 2019 Feb 26.

Asthma biologics: Underuse, overuse, and best use?

Ann Allergy Asthma Immunol. 2019 Apr;122(4):358-359. doi: 10.1016/j.anai.2018.12.016. Epub 2018 Dec 19.

Severe asthma and biologics: Data are good, listening to patients is better.

Ann Allergy Asthma Immunol. 2021 Sep;127(3):285-286. doi: 10.1016/j.anai.2021.05.017.

引用本文的文献

Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study.

Adv Ther. 2023 Nov;40(11):4836-4856. doi: 10.1007/s12325-023-02663-2. Epub 2023 Sep 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Biologics and Personalized Medicine in Severe Asthma: One Step at a Time.

J Allergy Clin Immunol Pract. 2023 Jun;11(6):1771-1772. doi: 10.1016/j.jaip.2023.04.022.

Biologics in asthma--the next step toward personalized treatment.

J Allergy Clin Immunol Pract. 2015 Mar-Apr;3(2):152-60; quiz 161. doi: 10.1016/j.jaip.2014.09.014.

Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.

MAbs. 2018 Jan;10(1):34-45. doi: 10.1080/19420862.2017.1392425. Epub 2017 Nov 14.

Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine.

Curr Opin Pulm Med. 2022 May 1;28(3):266-273. doi: 10.1097/MCP.0000000000000861. Epub 2022 Feb 7.

Biologics in severe asthma: Which one, When and Where?

Clin Exp Allergy. 2021 Sep;51(9):1225-1228. doi: 10.1111/cea.13989. Epub 2021 Jul 26.

Going Beyond "Bio-markers," Think "Life-markers".

Chest. 2020 Mar;157(3):503-505. doi: 10.1016/j.chest.2019.08.2210.

Severe T2-high asthma in the biologics era: European experts' opinion.

Eur Respir Rev. 2019 Jul 8;28(152). doi: 10.1183/16000617.0054-2019. Print 2019 Jun 30.

Biologics for paediatric severe asthma: trick or TREAT?

Lancet Respir Med. 2019 Apr;7(4):294-296. doi: 10.1016/S2213-2600(19)30045-1. Epub 2019 Feb 26.

Asthma biologics: Underuse, overuse, and best use?

Ann Allergy Asthma Immunol. 2019 Apr;122(4):358-359. doi: 10.1016/j.anai.2018.12.016. Epub 2018 Dec 19.

Severe asthma and biologics: Data are good, listening to patients is better.

Ann Allergy Asthma Immunol. 2021 Sep;127(3):285-286. doi: 10.1016/j.anai.2021.05.017.

引用本文的文献

Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study.

Adv Ther. 2023 Nov;40(11):4836-4856. doi: 10.1007/s12325-023-02663-2. Epub 2023 Sep 9.